VisionWave Holdings, Inc.
No SEC Form 4 filings for $VWAV in the last 30 days.
See all $VWAV insider activity →Aethlon Medical (AEMD) rose 390% after announcing a merger with North Immunology, raising $180M. Metalsource Mining (MSM) reported high-grade silver intercepts. VisionWave (VWAV) filed a patent for an AI counter-drone system.
VisionWave Holdings (VWAV) completed a $5M second closing with YA II PN, Ltd., issuing a convertible debenture and repricing a warrant. The $5M was used to repay part of a $20M note. The warrant's exercise price was cut to $1.50, but share issuances require shareholder approval due to Nasdaq rules.
VisionWave Holdings, Inc. (VWAV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Background As previously reported in the Current Report on Form 8-K filed by VisionWave Holdings, Inc. (the “ Company ”) with the Securities and Exchange Commission (the “ SEC ”) on July 21, 2026 (the “ July 8-K ”), on July 20
Over the past 7 days, AlphAI's AI scored 4 news stories mentioning VWAV (VisionWave Holdings, Inc.). Coverage has been balanced: 0 bullish, 4 neutral, and 0 bearish.
Recent VWAV coverage spans corporate actions, mergers & acquisitions and technology.
Patent filing signals progress in a defense AI niche, potentially boosting long‑term valuation.
Warrant repricing could increase upside potential for shareholders if the lower exercise price is exercised, while delayed debenture payments may affect liquidity.
The financing structure reduces cash but improves balance‑sheet liquidity; the warrant repricing could boost future equity dilution if approved.
The filing signals ongoing R&D but carries high execution risk; no revenue or prototype exists yet.
The filing signals long‑term strategic direction but provides no immediate financial impact.
AlphAI scores every news story that mentions VWAV with an AI model for sentiment and relevance, and aggregates insider trades from VisionWave Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Aethlon Medical (AEMD) rose 390% after announcing a merger with North Immunology, raising $180M. Metalsource Mining (MSM) reported high-grade silver intercepts. VisionWave (VWAV) filed a patent for an AI counter-drone system.
2 min readVisionWave Holdings (VWAV) completed a $5M second closing with YA II PN, Ltd., issuing a convertible debenture and repricing a warrant. The $5M was used to repay part of a $20M note. The warrant's exercise price was cut to $1.50, but share issuances require shareholder approval due to Nasdaq rules.
2 min readVisionWave Holdings, Inc. (VWAV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Background As previously reported in the Current Report on Form 8-K filed by VisionWave Holdings, Inc. (the “ Company ”) with the Securities and Exchange Commission (the “ SEC ”) on July 21, 2026 (the “ July 8-K ”), on July 20
2 min readVisionWave Holdings (Nasdaq: VWAV) filed a U.S. patent application for ARGUS, a space-enabled AI counter-drone system. The architecture combines space-based surveillance, AI, and ground sensors. The company notes no revenue, prototypes, or guarantees of patent approval or competitive advantage. ARGUS is in early development and requires significant capital and authorizations.
2 min readVisionWave Holdings (Nasdaq: VWAV) stock rose 13% to $0.5219 on news of its strategy for an integrated autonomous systems ecosystem. The company released a corporate overview outlining plans for interconnected autonomous platforms, sensing tech, and AI across defense, homeland security, and commercial markets. CEO Douglas Davis emphasized the goal of creating an ecosystem where autonomous ground and aerial platforms share capabilities. The company's technologies are in development and not yet co
2 min readVisionWave Holdings (VWAV) announced that shareholders approved a 1-for-250 reverse stock split and several other proposals, including executive compensation and director elections. However, the acquisition share deal with Foresight Autonomous Holdings (Foresight) failed to pass. The company had 27.58 million shares outstanding as of the record date.
2 min readVisionWave Holdings, Inc. (VWAV) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On September 1, 2026, VisionWave Holdings, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Meeting”) virtually at https://www.cstproxy.com/vwav/2026. At the Meeting, the Company’s stockholders
1 min readVisionWave (VWAV) plans to acquire 51% of CM Israel, an aerospace-certified composite manufacturer, for $2.5M in stock and a $5M loan. The deal aims to secure supply chains but remains subject to conditions, including a joint venture agreement. CM Israel generates revenue but faces growing pains. The transaction is not yet finalized.
3 min readVisionWave Holdings (NASDAQ: VWAV) updated investors on its pending deal to buy a 51% stake in C.M. Composite Materials Ltd. Completion is not closed and depends on conditions, including definitive JV agreements with Belrise Industries. VisionWave committed at least $5M funding to CM, plus a up to $5M loan at 12% interest.
6 min readVisionWave Holdings (VWAV) filed for international trademark protection for its AI platform, targeting the EU, UK, Israel, and UAE. The application covers AI, defense, robotics, and autonomous systems. The company also advanced its acquisition of Meteor Aerospace, reviewing its defense portfolio, including UAVs and EW systems. The deal is subject to regulatory approvals and due diligence.
2 min read
